Document is current
Any future updates will be listed below
-
Authors
Schmidt, Stanislaw
Bochennek, Konrad
Rudolph, Henriette
Lehrnbecher, Thomas https://orcid.org/0000-0002-6022-3439
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 9 February 2026
Accepted: 5 May 2026
First Online: 19 May 2026
Declarations
:
: Konrad Bochennek served at the speaker´s bureau of Merck/MSD and as consultant to Recordati Pharma. Henriette Rudolph has served at the speaker’s bureau of Merck/MSD and Pfizer. Thomas Lehrnbecher has received a grant from Gilead Sciences, has served as consultant to Gilead Sciences, Merck/MSD, Pharming, Mundipharma, Pfizer, Recordati Pharma and Roche, and served at the speaker´s bureau of Gilead Sciences, Merck/MSD, AstraZeneca, Pfizer, Sanofi Pasteur, Recordati Pharma, and Mundipharma. Stanislaw Schmidt has no conflict of interest to declare.
: Konrad Bochennek served at the speaker´s bureau of Merck/MSD and as consultant to Recordati Pharma. Henriette Rudolph has served at the speaker’s bureau of Merck/MSD and Pfizer. Thomas Lehrnbecher has received a grant from Gilead Sciences, has served as consultant to Gilead Sciences, Merck/MSD, Pharming, Mundipharma, Pfizer, Recordati Pharma and Roche, and served at the speaker´s bureau of Gilead Sciences, Merck/MSD, AstraZeneca, Pfizer, Sanofi Pasteur, Recordati Pharma, and Mundipharma. Stanislaw Schmidt has no conflict of interest to declare.
: All reported studies and experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards, including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines.
